These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Developmental and hormonal regulation of transforming growth factor-beta1 (TGFbeta1), -2, and -3 gene expression in isolated prostatic epithelial and stromal cells: epidermal growth factor and TGFbeta interactions. Itoh N, Patel U, Cupp AS, Skinner MK. Endocrinology; 1998 Mar; 139(3):1378-88. PubMed ID: 9492075 [Abstract] [Full Text] [Related]
3. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer. Nilsson E, Doraiswamy V, Parrott JA, Skinner MK. Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049 [Abstract] [Full Text] [Related]
4. Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen. Dallas SL, Zhao S, Cramer SD, Chen Z, Peehl DM, Bonewald LF. J Cell Physiol; 2005 Feb; 202(2):361-70. PubMed ID: 15389580 [Abstract] [Full Text] [Related]
5. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells. Gerdes MJ, Dang TD, Larsen M, Rowley DR. Endocrinology; 1998 Aug; 139(8):3569-77. PubMed ID: 9681509 [Abstract] [Full Text] [Related]
6. Differential effects of transforming growth factor-beta1 on cellular proliferation in the developing prostate. Tomlinson DC, Freestone SH, Grace OC, Thomson AA. Endocrinology; 2004 Sep; 145(9):4292-300. PubMed ID: 15192047 [Abstract] [Full Text] [Related]
7. Uncoordinated regulation of mRNA expression of the three isoforms of transforming growth factor-beta in the mouse skin carcinogenesis model. Rundhaug JE, Park J, Fischer SM. Mol Carcinog; 1997 Feb; 18(2):115-26. PubMed ID: 9049187 [Abstract] [Full Text] [Related]
8. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel HG. Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107 [Abstract] [Full Text] [Related]
9. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, and TGFbeta3) during embryonic rat testis development. Cupp AS, Kim G, Skinner MK. Biol Reprod; 1999 Jun; 60(6):1304-13. PubMed ID: 10330085 [Abstract] [Full Text] [Related]
10. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells. Story MT, Hopp KA, Meier DA. Prostate; 1996 Apr; 28(4):219-26. PubMed ID: 8602397 [Abstract] [Full Text] [Related]
11. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Barrack ER. Prostate; 1997 Apr 01; 31(1):61-70. PubMed ID: 9108888 [Abstract] [Full Text] [Related]
12. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition. Al-Azayzih A, Gao F, Somanath PR. Biochim Biophys Acta; 2015 May 01; 1853(5):1229-39. PubMed ID: 25746720 [Abstract] [Full Text] [Related]
20. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F, Lee J, Lu S, Pettaway CA, Dong Z. Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637 [Abstract] [Full Text] [Related] Page: [Next] [New Search]